(Q54776059)

3 June 2018

title

Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis. (English)

1 reference

3 June 2018

Spontaneous bacterial peritonitis

main subject

1 reference

1 reference

Ariza J

1

1 reference

3 June 2018

Gudiol F

2

1 reference

3 June 2018

Dolz C

3

1 reference

3 June 2018

Xiol J

4

1 reference

3 June 2018

Liñares J

5

1 reference

3 June 2018

Bosch J

6

1 reference

3 June 2018

Pallares R

7

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 September 1986

1 reference

3 June 2018

published in

Hepatology

1 reference

3 June 2018

volume

6

1 reference

3 June 2018

issue

5

1 reference

3 June 2018

page(s)

906-910

1 reference

3 June 2018

Pharmacokinetics and tissue penetration of azthreonam

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Pharmacology of aztreonam after intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Effects of cirrhosis on kinetics of aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Distribution of ceftazidime in ascitic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Antibiotic penetrance of ascitic fluid in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Enterococcal superinfection and colonization with aztreonam therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Spontaneous Bacterial Peritonitis in Cirrhosis: Endemic or Epidemic?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Treatment of serious gram-negative infections with aztreonam

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Aztreonam: worldwide overview of the treatment of patients with gram-negative infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Comparative clinical evaluation of aztreonam versus aminoglycosides in gram-negative septicaemia.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Aztreonam: the first monobactam

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

The passage of cephalothin into and out of ascitic fluid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Antibiotic concentrations in ascitic fluid of patients with ascites and bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Cefotaxime concentrations in ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Disposition of cefoxitin in patients with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060516

7 January 2021

Identifiers

DOI

10.1002/HEP.1840060516

1 reference

3 June 2018

PubMed ID

3530945

1 reference

3 June 2018